Fortress Biotech, Inc.
FBIO
$1.81
-$0.02-1.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 31.35% | 27.09% | -155.04% | 55.81% | 28.42% |
| Total Depreciation and Amortization | 0.00% | -5.62% | -19.65% | 1.19% | -51.13% |
| Total Amortization of Deferred Charges | -51.56% | -40.94% | -40.79% | -38.18% | -5.43% |
| Total Other Non-Cash Items | 57.07% | 80.07% | 30.98% | 48.33% | 43.59% |
| Change in Net Operating Assets | -152.60% | 68.42% | 41.10% | -141.18% | -7.83% |
| Cash from Operations | 22.94% | 63.05% | -19.55% | 34.40% | 41.26% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -42,757.14% | -- | -- | -- |
| Cash from Investing | -- | -23,709.52% | -- | -- | -- |
| Total Debt Issued | -- | -65.57% | -- | -- | -- |
| Total Debt Repaid | -- | -786.81% | 94.32% | -- | -- |
| Issuance of Common Stock | -89.93% | -92.75% | 706.01% | -- | -18.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 100.00% | 100.00% | 0.00% | 0.00% |
| Other Financing Activities | 177.10% | -6.14% | -511.62% | -5.64% | 80.22% |
| Cash from Financing | 87.16% | -40.84% | 200.97% | 146.95% | 25.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,265.05% | -124.37% | -19.93% | 88.48% | 109.50% |